Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Articles
BioCentury
|
Mar 2, 2015
Finance
China's 3SBio plans 2nd IPO
...of China (known as "Class I" drugs in China's regulatory framework). In December, 3SBio acquired
Shenzhen Sciprogen Bio-pharmaceutical Co. Ltd.
...
Read More
Items per page:
10
1 - 1 of 1
BioCentury
|
Mar 2, 2015
Finance
China's 3SBio plans 2nd IPO
...of China (known as "Class I" drugs in China's regulatory framework). In December, 3SBio acquired
Shenzhen Sciprogen Bio-pharmaceutical Co. Ltd.
...
Read More
Items per page:
10
1 - 1 of 1
Previous page
Next page